{
  "hash": "0fe886dddc99ad94ad31386c88895d3e",
  "result": {
    "markdown": "---\ntitle: \":orange_book: Malaria case study - Report #2\"\nexecute:\n  echo: false\n  warning: false\nfrom: markdown+emoji\ntoc: true\nnumber-sections: true\n---\n\n\n\n## Introduction\n\nIn this section we will explore the impact of the presence of research staff observing consultations as part of a Service Provision Assessment (SPA) on RCT data.\n\n:::callout-note\nAdd sensitivity analysis definition\n:::\n\n\n\n::: {.cell}\n\n:::\n\n\n\nThe data set used for this report is stored in **dataset2.dta**.\n\n\n\n::: {.cell}\n\n:::\n\n::: {.cell}\n\n:::\n\n::: {.cell}\n\n:::\n\n::: {.cell}\n\n:::\n\n::: {.cell}\n\n:::\n\n::: {.cell}\n\n:::\n\n::: {.cell}\n\n:::\n\n::: {.cell}\n\n:::\n\n\n\n## Descriptive statistics\n\n### Population characteristics\n\n\n\n::: {.cell}\n::: {.cell-output-display}\n|**Characteristic**          | **All**, N = 10,308 | **Observed**, N = 656 | **p-value** |\n|:---------------------------|:-------------------:|:---------------------:|:-----------:|\n|SDC_age_category            |                     |                       |     0.4     |\n|<2 months                   |     597 (5.8%)      |       40 (6.1%)       |             |\n|02-11 months                |     3,576 (35%)     |       206 (31%)       |             |\n|12-23 months                |     2,947 (29%)     |       209 (32%)       |             |\n|24-35 months                |     1,529 (15%)     |       96 (15%)        |             |\n|36-47 months                |     980 (9.5%)      |       67 (10%)        |             |\n|48-59 months                |     679 (6.6%)      |       38 (5.8%)       |             |\n|SDC_sex                     |                     |                       |     0.3     |\n|1                           |     5,229 (51%)     |       318 (49%)       |             |\n|2                           |     5,075 (49%)     |       337 (51%)       |             |\n|(Missing)                   |          4          |           1           |             |\n|CLIN_fever                  |                     |                       |    >0.9     |\n|0                           |     3,068 (30%)     |       193 (29%)       |             |\n|1                           |     7,225 (70%)     |       462 (70%)       |             |\n|98                          |      15 (0.1%)      |       1 (0.2%)        |             |\n|CLIN_fever_onset_category   |                     |                       |    0.034    |\n|                            |     3,083 (30%)     |       194 (30%)       |             |\n|<2 days                     |     1,998 (19%)     |       157 (24%)       |             |\n|>= 7 days                   |     343 (3.3%)      |       21 (3.2%)       |             |\n|2-3 days                    |     4,386 (43%)     |       248 (38%)       |             |\n|4-6 days                    |     498 (4.8%)      |       36 (5.5%)       |             |\n|CLIN_diarrhoea              |                     |                       |    0.019    |\n|0                           |     7,982 (77%)     |       477 (73%)       |             |\n|1                           |     2,306 (22%)     |       178 (27%)       |             |\n|98                          |      20 (0.2%)      |       1 (0.2%)        |             |\n|CLIN_cough                  |                     |                       |    0.055    |\n|0                           |     4,658 (45%)     |       270 (41%)       |             |\n|1                           |     5,635 (55%)     |       384 (59%)       |             |\n|98                          |      15 (0.1%)      |       2 (0.3%)        |             |\n|RX_preconsult_antibiotics   |                     |                       |    0.049    |\n|0                           |     8,573 (83%)     |       565 (86%)       |             |\n|1                           |     1,735 (17%)     |       91 (14%)        |             |\n|RX_preconsult_antimalarials |                     |                       |     0.6     |\n|0                           |     9,866 (96%)     |       631 (96%)       |             |\n|1                           |     442 (4.3%)      |       25 (3.8%)       |             |\n|CTX_district                |                     |                       |    0.001    |\n|Kaliua                      |     2,429 (24%)     |       149 (23%)       |             |\n|Sengerema                   |     2,703 (26%)     |       214 (33%)       |             |\n|Tanga                       |     5,176 (50%)     |       293 (45%)       |             |\n|CTX_area                    |                     |                       |   <0.001    |\n|rural                       |     4,088 (40%)     |       309 (47%)       |             |\n|urban                       |     6,220 (60%)     |       347 (53%)       |             |\n|CTX_facility_type           |                     |                       |   <0.001    |\n|dispensary                  |     5,599 (54%)     |       412 (63%)       |             |\n|health center               |     4,709 (46%)     |       244 (37%)       |             |\n:::\n:::\n\n\n### Clinical management\n\n\n\n::: {.cell}\n::: {.cell-output-display}\n|**Characteristic**          | **All**, N = 10,308 | **Observed**, N = 656 | **p-value** |\n|:---------------------------|:-------------------:|:---------------------:|:-----------:|\n|CALC_temperature_measured   |                     |                       |     0.5     |\n|0                           |     9,271 (90%)     |       595 (91%)       |             |\n|1                           |     1,037 (10%)     |       61 (9.3%)       |             |\n|CALC_fever_measured         |                     |                       |     0.6     |\n|0                           |      711 (69%)      |       40 (66%)        |             |\n|1                           |      326 (31%)      |       21 (34%)        |             |\n|(Missing)                   |        9,271        |          595          |             |\n|CALC_fever_all              |                     |                       |    >0.9     |\n|0                           |     3,056 (30%)     |       193 (29%)       |             |\n|1                           |     7,252 (70%)     |       463 (71%)       |             |\n|TEST_malaria_done           |     5,763 (56%)     |       367 (56%)       |    >0.9     |\n|TEST_malaria_type           |                     |                       |     0.4     |\n|1                           |     5,371 (93%)     |       339 (92%)       |             |\n|2                           |     340 (5.9%)      |       23 (6.3%)       |             |\n|95                          |      2 (<0.1%)      |        0 (0%)         |             |\n|98                          |      45 (0.8%)      |       5 (1.4%)        |             |\n|(Missing)                   |        4,550        |          289          |             |\n|TEST_malaria_result         |                     |                       |     0.5     |\n|0                           |     4,665 (81%)     |       289 (79%)       |             |\n|1                           |     1,032 (18%)     |       76 (21%)        |             |\n|2                           |      1 (<0.1%)      |        0 (0%)         |             |\n|95                          |      3 (<0.1%)      |        0 (0%)         |             |\n|98                          |      57 (1.0%)      |       2 (0.5%)        |             |\n|(Missing)                   |        4,550        |          289          |             |\n|DX_severe                   |     254 (2.5%)      |       10 (1.5%)       |    0.13     |\n|DX_malaria                  |     1,800 (17%)     |       116 (18%)       |     0.9     |\n|DX_malaria_severe           |     148 (1.4%)      |       6 (0.9%)        |     0.3     |\n|RX_antimalarials            |     1,290 (13%)     |       114 (17%)       |   <0.001    |\n|RX_antimalarial_parenteral  |     249 (2.4%)      |       29 (4.4%)       |    0.002    |\n|RX_antibiotics              |     5,430 (53%)     |       351 (54%)       |     0.7     |\n|MGMT_referral_src_caregiver |                     |                       |     0.2     |\n|0                           |    10,122 (98%)     |       640 (98%)       |             |\n|1                           |     164 (1.6%)      |       14 (2.1%)       |             |\n|97                          |      9 (<0.1%)      |       2 (0.3%)        |             |\n|98                          |      13 (0.1%)      |        0 (0%)         |             |\n|MGMT_referral_src_registry  |     114 (1.1%)      |       8 (1.2%)        |     0.8     |\n:::\n:::\n\n\n\n## From fever assessment to malaria treatment\n\n### RCT population\n\n::: column-page\n\n\n::: {.cell}\n::: {.cell-output-display}\n![](malaria_case_study_02_report_files/figure-pdf/unnamed-chunk-12-1.pdf)\n:::\n:::\n\n\n:::\n\n### SPA (sub)-population\n\n::: column-page\n\n\n::: {.cell}\n::: {.cell-output-display}\n![](malaria_case_study_02_report_files/figure-pdf/unnamed-chunk-13-1.pdf)\n:::\n:::\n\n\n:::",
    "supporting": [
      "malaria_case_study_02_report_files"
    ],
    "filters": [
      "rmarkdown/pagebreak.lua"
    ],
    "includes": {},
    "engineDependencies": {
      "knitr": [
        "{\"type\":\"list\",\"attributes\":{},\"value\":[]}"
      ]
    },
    "preserve": null,
    "postProcess": false
  }
}